2Ginsberg RJ, Vokes EE, Raben A. Non-small-cell lung cancer[A]. De Vita JI, Hellman S, Rosenberg SR.Cancer: principles and Practice of Oncology[M]. 5th edition, Philadelphia, Pensylvania: Lippincott-Raven,1997:858-911.
3Belani CP, Natale RB, Lee JS, et al. Randomized phase Ⅲ trial comparing cisplatin/etoposide versus carboplatin/paclitaxel in advanced and metastatic non-small-cell lung cancer(Meeting Abstr)[J]. Proc Am Soc Clin Oncol,1998,17: 455-458.
4Belani CP, Aisner J, Hiponia D, et al. Paclitaxel and carboplatin with concurrent thoracic radiotherapy for regionally advanced non-small-cell cancer (NSCLC)(Meeting Abstr)[J].Proc Ann Meet Am Soc Clin Oncol,1996,15:A1201.
5Kosmidis P ,Mylonakis N, Skarlos D , et al. Paclitaxe(175mg/m2) plus carboplatin (6 AUC) versus Paclitaxel (225mg/m2) plus carboplatin (6 AUC ) in advanced non-small-cell cancer(NSCLC): a multicenter randomized trail. Hellenic Cooperative Oncology Group (
6Chen YM, Perng RP, Lee YC, et al. Paclitaxel plus carboplatin compared with paclitaxel plus gemcitabine shows similar efficacy while more cost-effective: a randomized phase Ⅱ study of combination chemotherapy against inoperable non-small-cell lung cancer
7Kim NK,Park YS,Heo DS,et al.A phase Ⅲ randomized study of 5-fluorouracil and cisplatin versus fluorouracil,doxorubicin,and mitomycin C versus 5-fluorouracil alone in the treatment of gastric cancer[J].Cancer,1993,71 (12):3813-3819.
8Sasaki T,Maeda Y,Kobaysahi T,et al.Standard chemotherapy for gastrointestnal malignancies based on evidence[J].Jpn J Cancer Chemother,2000,27(2):166-176.
9Roth AD,Ajani J.Docetaxel based chemotherapy in the treatment of gastric cancer[J].Ann Oncol,2003,14(Suppl 2):1141-1144.
10Thuss-Patience PC,Kretzschmar A,Krenn V,et al.Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-Fu continuous infusion[J].Onkologie,2003,26 (1):63-65.
